摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-丙二醇,3-(4-氯苯氧基)-,(2R)- | 112652-61-6

中文名称
1,2-丙二醇,3-(4-氯苯氧基)-,(2R)-
中文别名
——
英文名称
(R)-3-(4-chlorophenoxy)propane-1,2-diol
英文别名
(R)-3-(p-chlorophenoxy)propane-1,2-diol;(2R)-3-(4-chlorophenoxy)propane-1,2-diol
1,2-丙二醇,3-(4-氯苯氧基)-,(2R)-化学式
CAS
112652-61-6
化学式
C9H11ClO3
mdl
——
分子量
202.638
InChiKey
MXOAEAUPQDYUQM-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    83 °C
  • 沸点:
    369.5±27.0 °C(Predicted)
  • 密度:
    1.317±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    3

SDS

SDS:638e932d73fd93698473e964dfb6493e
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,2-丙二醇,3-(4-氯苯氧基)-,(2R)-叠氮基三甲基硅烷偶氮二甲酸二异丙酯 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 (R)-3-azido-1-O-(4'-chlorophenyl)-1,2-propanediol
    参考文献:
    名称:
    Regioselective and Stereospecific Azidation of 1,2- and 1,3-Diols by Azidotrimethylsilane via a Mitsunobu Reaction
    摘要:
    A one-pot regio- and stereospecific azidation reaction of 1,2- and 1,3-diols with azidotrimethylsilane (Me3SiN3) via a Mitsunobu reaction has been achieved. With 1,2- and 1,3-diols, the reaction of triphenylphosphine, diisopropyl azodicarboxylate, and Me3SiN3 in dichloromethane gave regioselective azidation at C-2 and C-3, respectively, in good yield (74-90% combined yield of 1a + 1b or of 2a + 2b). However, application of the same reaction conditions to a 1,4-diol led to the exclusive formation of the cyclic ether. The regioselectivity of this one-pot reaction is influenced by the solvent, the degree of steric bulk at C-2 of the 1,2-diol or at C-3 of the 1,3-diol, and the presence of electron-donating and electron-withdrawing groups near the secondary carbinol carbon. This selectivity is discussed in terms of the mechanistic model proposed by Mathieu-Pelta and Evans (Mathieu-Pelta, I.; Evans, S. A., Jr. J. Org. Chem. 1898, 57, 3409-3413), which involves reaction of the dioxaphospholane intermediate with Me3SiN3 to form oxyphosphonium ions 4 and 5.
    DOI:
    10.1021/jo9906375
  • 作为产物:
    描述:
    氯苯甘醚吡啶4-二甲氨基吡啶 、 baker's yeast 、 草酰氯 、 sodium phosphate buffer 、 二甲基亚砜三乙胺蔗糖 作用下, 以 二氯甲烷 为溶剂, 反应 2.83h, 生成 1,2-丙二醇,3-(4-氯苯氧基)-,(2R)-
    参考文献:
    名称:
    Baker's yeast mediated stereoselective biotransformation of 1-acetoxy-3-aryloxypropan-2-ones
    摘要:
    A series of 1-acetoxy-3-aryloxypropan-2-ones la-m were synthesized and subjected to biotransformation by baker's yeast yielding optically active monoacetates 5 or ent-5 and/or diols 4 of moderate to excellent enantiomeric purity. The dependence of the reduction/hydrolysis ratio and stereoselectivity on the size and substitution pattern of the aromatic moiety in the substrate is also discussed. (C) 1998 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0957-4166(97)00626-5
点击查看最新优质反应信息

文献信息

  • THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS
    申请人:Cravo Daniel
    公开号:US20110034505A1
    公开(公告)日:2011-02-10
    The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in claim 1 , including pharmaceutical compositions thereof and for their use in the treatment and/or prevention of diseases and disorders modulated by AMP agonists. The invention is also directed to intermediates and to a method of preparation of compounds of formula (I).
    本发明涉及式(I)化合物,其中R1、R2和R3如权利要求1所定义,包括其药物组合物以及用于治疗和/或预防由AMP激动剂调节的疾病和紊乱的用途。该发明还涉及中间体和式(I)化合物的制备方法。
  • PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE
    申请人:FUJIFILM Corporation
    公开号:US20130171415A1
    公开(公告)日:2013-07-04
    Disclosed is a photosensitive resin composition comprising: (Component A) an oxime sulfonate compound represented by Formula (1); (Component B) a resin comprising a constituent unit having an acid-decomposable group that is decomposed by an acid to form a carboxyl group or a phenolic hydroxy group; and (Component C) a solvent wherein in Formula (1) R 1 denotes an alkyl group, an aryl group, or a heteroaryl group, each R 2 independently denotes a hydrogen atom, an alkyl group, an aryl group, or a halogen atom, Ar 1 denotes an o-arylene group or an o-heteroarylene group, X denotes O or S, and n denotes 1 or 2, provided that of two or more R 2 s present in the compound, at least one denotes an alkyl group, an aryl group, or a halogen atom.
    揭示了一种光敏树脂组合物,包括:(组分A)由式(1)表示的磺酸盐化合物;(组分B)包括具有可被酸分解的基团的树脂,该基团通过酸分解形成羧基或羟基;和(组分C)溶剂 其中在式(1)中,R1表示烷基、芳基或杂芳基,每个R2独立地表示原子、烷基、芳基或卤素原子,Ar1表示邻芳撑基或邻杂芳撑基,X表示O或S,n表示1或2,前提是在化合物中存在两个或两个以上的R2时,至少有一个表示烷基、芳基或卤素原子。
  • Integrase inhibitors
    申请人:Cai R. Zhenhong
    公开号:US20080058315A1
    公开(公告)日:2008-03-06
    Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    三环化合物,其受保护的中间体,以及用于抑制HIV整合酶的方法被披露。
  • 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
    申请人:JENKEM TECHNOLOGY CO., LTD. (BEIJING)
    公开号:US20160272604A1
    公开(公告)日:2016-09-22
    Disclosed are a 3-furyl-2-cyano-2-acrylamide derivative with epidermal growth factor receptor (EGFR) inhibitory activity and pharmaceutical acceptable salt thereof, together with preparation method thereof, pharmaceutical composition comprising the compound, and application of the compound in treating senile dementia (AD). The new compound is shown as formula I, wherein R 1 is selected from the group consisting of H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl and C 3 -C 6 cycloalkyl; R 2 is selected from the group consisting of alkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, aralkyl and heteroaralkyl; X is selected from the group consisting of CH 2 , NH, O and S; m and n are all integers greater than or equal to zero.
    揭示了一种具有表皮生长因子受体(EGFR)抑制活性的3-呋喃基-2-基-2-丙烯酰胺生物及其药用可接受盐,以及其制备方法,包含该化合物的药物组合物,以及该化合物在治疗老年性痴呆症(AD)中的应用。新化合物的化学式如下,其中R1选自H、C1-C6烷基、C2-C6基、C2-C6炔基和C3-C6环烷基组成的群;R2选自烷基、环烷基、基、炔基、芳基、杂芳基、芳基烷基和杂芳基烷基组成的群;X选自CH2、NH、O和S组成的群;m和n均为大于或等于零的整数。
  • Asymmetric hydrolytic kinetic resolution with recyclable polymeric Co(<scp>iii</scp>)–salen complexes: a practical strategy in the preparation of (S)-metoprolol, (S)-toliprolol and (S)-alprenolol: computational rationale for enantioselectivity
    作者:Tamal Roy、Sunirmal Barik、Manish Kumar、Rukhsana I. Kureshy、Bishwajit Ganguly、Noor-ul H. Khan、Sayed H. R. Abdi、Hari C. Bajaj
    DOI:10.1039/c4cy00594e
    日期:——
    epoxide (up to 46% compared to 50% theoretical yield) along with high enantioselectivity (up to 99%) were obtained in most cases using catalyst 1. Further studies showed that catalyst 1 could retain its catalytic activity for six cycles under the present reaction conditions without any significant loss in activity or enantioselectivity. To show the practical applicability of the above synthesized catalyst
    合成了一系列基于许多非手性和手性连接基的手性聚合Co(III)-salen配合物,并在末端环氧化物的不对称解动力学拆分中评估了它们的催化性能。明智地研究了该连接基的作用,发现在手性BINOL型聚合物Salen配合物1的情况下,未反应的环氧化物催化剂反应性和对映选择性的增加,特别是在短和短的情况下。长链脂族环氧化物。在大多数情况下,使用催化剂1可获得良好的分离度,即未反应的环氧化物的收率高(高达50%的理论收率的46%),以及高对映选择性(高达99%)。进一步的研究表明,催化剂在当前的反应条件下,图1所示的催化剂可以保持其催化活性六个循环而没有任何活性或对映选择性的明显损失。为了显示上述合成催化剂的实际适用性,我们使用配合物1以中等收率和高对映选择性合成了一些有效的手性β-阻滞剂。DFT(M06-L / 6-31 + G ** // ONIOM(B3LYP / 6-31G *:STO-3
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯